A new research has been made in California in order to see if the prostate vaccine against cancer is basically helpful. In July1, 2006 the Journal of Clinical Oncology printed the first conclusions of this research. Scientists mentioned that the speed of survival increased by four and a half months in those that had been administered the cancer vaccine in contrast with those that got the placebo. The study was made on sufferers with asymptomatic metastatic hormone refractory prostate cancer (HRPC) and was designed for observing if the illness progression will be delayed and sufferers will survive longer. The vaccine was properly tolerated by sufferers and the unwanted effects were mild: fever and chills.

The conclusions have been that 115 sufferers of this group had progressive disease at the time of information analysis and all sufferers had been followed for survival for 3 years. For these treated with sipuleucel-T the …

Read More